BioSpace News Archive

The FDA’s focus on both safety and innovation stems from our historic mission to protect and promote public health—to assure that medical devices on the U.S. market are high-quality, safe and effective and to facilitate innovation and assure that patients and providers have timely and continued access to these high-quality, safe and effective devices.

Peli BioThermal, the global name in temperature controlled packaging, is exhibiting its award-winning shipper solutions and services at Arab Health for the first time as the company increases its infrastructure and operations in the Middle East.

“After having shoulder surgery, I had to have help putting on shirts and blouses,” said an inventor from Cedar Hill, Texas. “This inspired me to develop a better garment which may allow wearers to easily dress without assistance or with the aid of a caregiver.”

Tivity Health®, Inc. (NASDAQ:TVTY) today announced preliminary unaudited financial results for the quarter and year ended December 31, 2018.

Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the fourth quarter and full-year 2018 after the close of market on Monday, February 25, 2019.

First Patients Dosed with Company’s Novel Bispecific Antibody Format in Phase I/II Clinical Trial

Provention is currently developing PRV-101 as a polyvalent vaccine for acute coxsackie virus infection and to potentially prevent the onset of T1D

Providing a consistent and reliable channel of communication between providers, caregivers, residents and families.

Integrated network matches at-risk community with unique prevention program

Clinical Proof-of-Concept Data Expected in Second Half of 2019